Role of proliferative markers in breast lesions

被引:1
|
作者
Manna, Asim Kumar [1 ]
Pathak, Swapan [1 ]
Sarkar, Diptendra Kumar [2 ]
机构
[1] IPGME&R, Dept Pathol, Kolkata, India
[2] IPGME&R, Dept Surg, Kolkata, India
关键词
Breast lesions; Proliferative markers; DUCTAL CARCINOMA;
D O I
10.1007/s12262-010-0010-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Carcinoma of breast is a leading cause of death in women throughout the world. Difficulty in diagnosis occurs in routine Hematoxylin and Eosin (H&E) stained sections to differentiate premalignant lesions like epitheliosis and malignant lesions like carcinoma in situ which may affect prognosis. Our study was done to assess the role of proliferative markers in this field. In this study, total 66 cases of different breast lesions were studied by H&E stained sections as well as proliferative markers like silver staining nucleolar organizer region (AgNOR) and proliferating cell nuclear antigen (PCNA). Statistically significant differences found in expression of proliferative markers between most of them. Study of proliferative markers help in the proper diagnosis of different breast lesions which lies in the grey zone on routine histopathology.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 50 条
  • [31] Clonal evolution of atypical proliferative lesions into breast cancers
    Nishimura, Tomomi
    Yoshida, Kenichi
    Kawata, Yukiko
    Takeuchi, Yasuhide
    Kakiuchi, Nobuyuki
    Shiozawa, Yusuke
    Aoki, Kosuke
    Hirata, Masahiro
    Kataoka, Tatsuki R.
    Sakurai, Takaki
    Shiraishi, Yuichi
    Chiba, Kenichi
    Takeuchi, Kengo
    Haga, Hironori
    Miyano, Satoru
    Toi, Masakazu
    Ogawa, Seishi
    CANCER RESEARCH, 2018, 78 (13)
  • [32] BENIGN AND MALIGNANT PROLIFERATIVE EPITHELIAL LESIONS OF THE BREAST - A REVIEW
    AZZOPARDI, JG
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (12): : 1717 - 1720
  • [33] Automated Classification of Benign and Malignant Proliferative Breast Lesions
    Radiya-Dixit, Evani
    Zhu, David
    Beck, Andrew H.
    SCIENTIFIC REPORTS, 2017, 7
  • [34] Raman spectroscopic analysis of atypical proliferative lesions of the breast
    Subramanian, K.
    Kendall, C.
    Stone, N.
    Brown, J. C.
    McCarthy, K.
    Bristol, J.
    Chan, Y. H.
    IMAGING, MANIPULATION, AND ANALYSIS OF BIOMOLECULES, CELLS, AND TISSUES IV, 2006, 6088
  • [35] Precursors and preinvasive lesions of the breast: The role of molecular prognostic markers in the diagnostic and therapeutic dilemma
    Zagouri F.
    Sergentanis T.N.
    Zografos G.C.
    World Journal of Surgical Oncology, 5 (1)
  • [36] ROLE OF PAPILLOMA-VIRUS IN PROLIFERATIVE SQUAMOUS LESIONS
    JENSON, AB
    LIM, LY
    LANCASTER, WD
    SURVEY AND SYNTHESIS OF PATHOLOGY RESEARCH, 1985, 4 (01): : 8 - 13
  • [37] Biologic markers in small cancers of the breast and breast preneoplastic lesions
    Krogerus, L
    Leivonen, M
    Hästö, AL
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S113 - S113
  • [38] Different proliferative patterns characterize different preinvasive breast lesions
    Vlacava, P
    Naccarato, AG
    Bevilacqua, G
    JOURNAL OF PATHOLOGY, 1999, 188 (03): : 245 - 251
  • [39] THE IMMUNOHISTOCHEMICAL DEMONSTRATION OF ACTIN IN MYOEPITHELIAL CELLS IN PROLIFERATIVE LESIONS OF THE BREAST
    WALTHER, B
    RUTTER, G
    STEGNER, HE
    BOCKER, W
    PATHOLOGE, 1986, 7 (06): : 318 - 323
  • [40] Telomerase activity (TA) is not a marker of malignancy in proliferative breast lesions
    Poremba, C
    Willenbring, H
    Schäfer, KL
    Diallo, R
    Otterbach, F
    Dockhorn-Dworniczak, B
    Böcker, W
    LABORATORY INVESTIGATION, 1998, 78 (01) : 25A - 25A